X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Procter & Gamble Health with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs FULFORD INDIA - Comparison Results

PROCTER & GAMBLE HEALTH    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH FULFORD INDIA PROCTER & GAMBLE HEALTH/
FULFORD INDIA
 
P/E (TTM) x 61.0 398.8 15.3% View Chart
P/BV x 10.7 6.2 171.5% View Chart
Dividend Yield % 0.3 0.1 376.2%  

Financials

 PROCTER & GAMBLE HEALTH   FULFORD INDIA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
FULFORD INDIA
Mar-14
PROCTER & GAMBLE HEALTH/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,358942 144.1%   
Low Rs933450 207.3%   
Sales per share (Unadj.) Rs665.0691.4 96.2%  
Earnings per share (Unadj.) Rs56.611.5 493.6%  
Cash flow per share (Unadj.) Rs72.515.4 471.9%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %1.30.3 455.8%  
Book value per share (Unadj.) Rs441.7380.0 116.2%  
Shares outstanding (eoy) m16.603.90 425.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.0 171.1%   
Avg P/E ratio x20.260.7 33.3%  
P/CF ratio (eoy) x15.845.3 34.9%  
Price / Book Value ratio x2.61.8 141.6%  
Dividend payout %26.517.4 151.9%   
Avg Mkt Cap Rs m19,0112,714 700.4%   
No. of employees `0001.50.4 347.7%   
Total wages/salary Rs m1,696505 335.9%   
Avg. sales/employee Rs Th7,150.06,073.0 117.7%   
Avg. wages/employee Rs Th1,098.71,137.4 96.6%   
Avg. net profit/employee Rs Th608.2100.7 604.1%   
INCOME DATA
Net Sales Rs m11,0402,696 409.4%  
Other income Rs m240125 191.1%   
Total revenues Rs m11,2792,822 399.7%   
Gross profit Rs m1,376-46 -2,965.9%  
Depreciation Rs m26415 1,736.8%   
Interest Rs m010 0.0%   
Profit before tax Rs m1,35254 2,489.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m58310 6,070.8%   
Profit after tax Rs m93945 2,100.9%  
Gross profit margin %12.5-1.7 -724.4%  
Effective tax rate %43.117.7 243.8%   
Net profit margin %8.51.7 513.1%  
BALANCE SHEET DATA
Current assets Rs m7,5231,738 432.8%   
Current liabilities Rs m2,253545 413.5%   
Net working cap to sales %47.744.3 107.9%  
Current ratio x3.33.2 104.7%  
Inventory Days Days5248 107.6%  
Debtors Days Days414 942.1%  
Net fixed assets Rs m1,24012 10,417.6%   
Share capital Rs m16639 425.6%   
"Free" reserves Rs m7,1671,443 496.6%   
Net worth Rs m7,3331,482 494.8%   
Long term debt Rs m00-   
Total assets Rs m9,9122,077 477.3%  
Interest coverage xNM6.7-  
Debt to equity ratio x00-  
Sales to assets ratio x1.11.3 85.8%   
Return on assets %9.52.6 363.0%  
Return on equity %12.83.0 424.6%  
Return on capital %20.84.3 482.1%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m1,01517 5,898.8%   
Fx outflow Rs m3,043673 452.0%   
Net fx Rs m-2,028-656 309.2%   
CASH FLOW
From Operations Rs m53790 596.2%  
From Investments Rs m-476105 -455.4%  
From Financial Activity Rs m-220-14 1,558.9%  
Net Cashflow Rs m-160181 -88.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 3.8 478.9%  
FIIs % 1.0 0.1 1,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 21.2 137.3%  
Shareholders   28,591 4,783 597.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views on News

PROCTER & GAMBLE HEALTH at All Time High; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Jul 16, 2019 | Updated on Jul 16, 2019

PROCTER & GAMBLE HEALTH share price has hit an all time high at Rs 4,768 (up 9.3%). The BSE HEALTHCARE Index is up by 0.9%. Among the top gainers in the BSE HEALTHCARE Index today are PROCTER & GAMBLE HEALTH (up 9.3%) and SANOFI INDIA (up 0.5%). The top losers include BLISS GVS PHARMA (down 0.2%) and NARAYANA HRUDAYALAYA LTD (down 0.2%).

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 16, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - VENUS REMEDIES COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS